Erik A. Sistermans

11.7k citations

123 papers · 5.6k indexed · 1 hit paper · h-index 37

Molecular Biology top 2%
Genetics top 0.5%
Pediatrics, Perinatology and Child Health top 1%
Plant Science top 5%
Cancer Research top 5%

Co-authors: Bert B.A. de Vries Willy M. Nillesen Ilse J. de Wijs David A. Koolen Nicole de Leeuw Marjan M. Weiss Rolph Pfundt Marcel Reinders
Topics: Prenatal Screening and Diagnostics (37 papers)Genomic variations and chromosomal abnormalities (30 papers)Fetal and Pediatric Neurological Disorders (21 papers)
Cited by: Genetics Pediatrics, Perinatology and Child Health Molecular Biology
Journals: Nucleic Acids Research Nature GeneticsSHILAP Revista de lepidopterología
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Erik A. Sistermans

120 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Germline KRAS mutations cause Noonan syndrome

2006 514 citations Erik A. Sistermans et al. profile →

Peers

Countries citing papers authored by Erik A. Sistermans

Since Specialization

Citations

This map shows the geographic impact of Erik A. Sistermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik A. Sistermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik A. Sistermans more than expected).

Fields of papers citing papers by Erik A. Sistermans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik A. Sistermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik A. Sistermans. The network helps show where Erik A. Sistermans may publish in the future.

Co-authorship network of co-authors of Erik A. Sistermans

This figure shows the co-authorship network connecting the top 25 collaborators of Erik A. Sistermans. A scholar is included among the top collaborators of Erik A. Sistermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik A. Sistermans. Erik A. Sistermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluating the effectiveness of pre-operative diagnosis of ovarian cancer using minimally invasive liquid biopsies by combining serum human epididymis protein 4 and cell-free DNA in patients with an ovarian mass 2024 ·International Journal of Gynecological Cancer ·(unknown),(unknown),Erik A. Sistermans,(unknown),Hugo M. Horlings,Constantijne H. Mom,Marcel Reinders,Frédéric Amant,Daan van den Broek,Lodewyk F.A. Wessels,Christianne Lok,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	3
2	Implementing non-invasive prenatal testing in a national screening program: Lessons learned from the TRIDENT studies 2024 ·Best Practice & Research Clinical Obstetrics & Gynaecology ·(unknown),Malgorzata I. Srebniak,Lidewij Henneman,Erik A. Sistermans,Karuna R. M. van der Meij	1
3	In Vitro CRISPR-Cas12a-Based Detection of Cancer-Associated TP53 Hotspot Mutations Beyond the crRNA Seed Region 2023 ·The CRISPR Journal ·(unknown),(unknown),Arjen Brink,Ruud H. Brakenhoff,Erik A. Sistermans,Rob M.F. Wolthuis	12
4	Fetal fraction of cell-free DNA in noninvasive prenatal testing and adverse pregnancy outcomes: a nationwide retrospective cohort study of 56,110 pregnant women 2023 ·American Journal of Obstetrics and Gynecology ·(unknown),P Scheffer,Jens Henrichs,Caroline J. Bax,Neeltje Crombag,Marjan M. Weiss,Merryn Macville,Diane Van Opstal,Elles M. J. Boon,Erik A. Sistermans,Lidewij Henneman,Ewoud Schuit,Mireille N. Bekker	10
5	Association between low fetal fraction in cell‐free DNA screening and fetal chromosomal aberrations: A systematic review and meta‐analysis 2023 ·Prenatal Diagnosis ·(unknown),Ewoud Schuit,(unknown),Erik A. Sistermans,Lidewij Henneman,Mireille N. Bekker,P Scheffer	4
6	Non‐invasive prenatal testing for everybody or contingent screening? 2022 ·Prenatal Diagnosis ·Karuna R. M. van der Meij,Lidewij Henneman,Erik A. Sistermans	5
7	The cell‐free DNA virome of 108,349 Dutch pregnant women 2022 ·Prenatal Diagnosis ·(unknown),(unknown),Matthijs R. A. Welkers,Erik A. Sistermans	16
8	Uptake of fetal aneuploidy screening after the introduction of the non‐invasive prenatal test: A national population‐based register study 2021 ·Acta Obstetricia Et Gynecologica Scandinavica ·Karuna R. M. van der Meij,(unknown),Ellen W. S. Carbo,(unknown),Wendy Rodenburg,Erik A. Sistermans,Martina C. Cornel,Lidewij Henneman	30
9	International Society for Prenatal Diagnosis Position Statement: cell free (cf)DNA screening for Down syndrome in multiple pregnancies 2020 ·Prenatal Diagnosis ·Glenn E. Palomaki,Rossa W. K. Chiu,Mark D. Pertile,Erik A. Sistermans,Yuval Yaron,Joris Vermeesch,Neeta L. Vora,Robert G. Best,Louise Wilkins‐Haug	41
10	The bivariate NRIP1/ZEB2 RNA marker permits non-invasive presymptomatic screening of pre-eclampsia 2020 ·Scientific Reports ·(unknown),Allerdien Visser,Remco Keijser,(unknown),Ankie Poutsma,Joyce Mulders,(unknown),(unknown),Aldo Jongejan,Eva Pajkrt,Erik A. Sistermans,Daoud Sie,Myron G. Best,Tom Würdinger,Marjon A. de Boer,Gijs Afink,Cees B.M. Oudejans	5
11	A novel CCM2 variant in a family with non‐progressive cognitive complaints and cerebral microbleeds 2016 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Petra E. Cohn‐Hokke,Henne Holstege,Marjan M. Weiss,Wiesje M. van der Flier,Frederik Barkhof,Erik A. Sistermans,Yolande A.L. Pijnenburg,John C. van Swieten,Hanne Meijers‐Heijboer,Philip Scheltens	4
12	Trial by Dutch laboratories for evaluation of non‐invasive prenatal testing. Part I—clinical impact 2016 ·Prenatal Diagnosis ·Dick Oepkes,Godelieve C.M.L. Page‐Christiaens,Caroline J. Bax,Mireille N. Bekker,Catia M. Bilardo,Elles M. J. Boon,G. Heleen Schuring‐Blom,A. Coumans,Brigitte H. W. Faas,Robert‐Jan H. Galjaard,Attie T. J. I. Go,Lidewij Henneman,Merryn Macville,Eva Pajkrt,Ron F. Suijkerbuijk,Karin Huijsdens–van Amsterdam,Diane Van Opstal,E. J. T. Verweij,Marjan M. Weiss,Erik A. Sistermans	110
13	A novel homozygous 5 bp deletion in FKBP10 causes clinically Bruck syndrome in an Indonesian patient 2011 ·European Journal of Medical Genetics ·(unknown),Fleur S. van Dijk,Jan M. Cobben,Rick R. van Rijn,Erik A. Sistermans,Sultana MH Faradz,(unknown),Gerard Pals	23
14	Monitoring Standards for Molecular Genetic Testing in the United Kingdom, The Netherlands, and Ireland 2006 ·Genetic Testing ·Simon Ramsden,Zandra C. Deans,David Robinson,Roger Mountford,Erik A. Sistermans,Wayne W. Grody,Shirley McQuaid,Simon Patton,(unknown)	27
15	A novel 2.3 Mb microduplication of 12q24.21q24.23 detected by genome-wide tiling-path resolution array comparative genomic hybridization in a girl with syndromic mental retardation 2006 ·Clinical Dysmorphology ·(unknown),David A. Koolen,Rolph Pfundt,Nicole de Leeuw,(unknown),Erik A. Sistermans,Joris A. Veltman,Bert B.A. de Vries	7
16	Interstitial 2.2 Mb deletion at 9q34 in a patient with mental retardation but without classical features of the 9q subtelomeric deletion syndrome 2006 ·American Journal of Medical Genetics Part A ·Tjitske Kleefstra,David A. Koolen,Willy M. Nillesen,Nicole de Leeuw,Ben C.J. Hamel,Joris A. Veltman,Erik A. Sistermans,Hans van Bokhoven,(unknown),Bert B.A. de Vries	16
17	Cerebrotendinous xanthomatosis: report of two Brazilian brothers 2004 ·Arquivos de Neuro-Psiquiatria ·Marcos Christiano Lange,Viviane Flumignan Zétola,Hélio Afonso Ghizoni Teive,Rosana Hermínia Scola,(unknown),Jorge A. Zavala,(unknown),Salmo Raskin,Lineu César Werneck,Erik A. Sistermans	8
18	Mutation detection in the aspartoacylase gene in 17 patients with Canavan disease: four new mutations in the non-Jewish population 2000 ·European Journal of Human Genetics ·Erik A. Sistermans,I.F.M. de Coo,(unknown),Bwee Tien Poll‐The,Wim J. Kleijer,Bernard A. van Oost	33
19	Gene symbol: PLP. Disease: Pelizaeus-Merzbacher disease. 1999 ·Human Genetics ·Erik A. Sistermans,Ilse J. de Wijs,(unknown),(unknown)	2
20	Tissue- and cell-specific distribution of creatine kinase B: A new and highly specific monoclonal antibody for use in immunohistochemistry 1995 ·Cell and Tissue Research ·Erik A. Sistermans,Yvette J.M. de Kok,Wilma Peters,(unknown),P. H. K. Jap,B. Wieringa	53

About Erik A. Sistermans

Erik A. Sistermans is a scholar working on Genetics, Pediatrics, Perinatology and Child Health and Cancer Research, having authored 123 papers that have together received 5.6k indexed citations. Recurring topics across this work include Prenatal Screening and Diagnostics (37 papers), Genomic variations and chromosomal abnormalities (30 papers) and Fetal and Pediatric Neurological Disorders (21 papers). The work is most often cited by research in Genetics (2.7k citations), Pediatrics, Perinatology and Child Health (1.0k citations) and Molecular Biology (2.9k citations). Erik A. Sistermans has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Bert B.A. de Vries, Willy M. Nillesen, Ilse J. de Wijs, David A. Koolen, Nicole de Leeuw, Marjan M. Weiss, Rolph Pfundt, Marcel Reinders, Roy Straver and Cees B.M. Oudejans. Their work appears in journals such as Nucleic Acids Research, Nature Genetics and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact